跳至主要内容
临床试验/CTRI/2014/08/004838
CTRI/2014/08/004838尚未招募未知

Efficacy and safety study of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) on cotinine level and oxidative stress marker in chronic smokers having mild to moderate hyperlipidemia

Olive Lifesciences Pvt Ltd0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Men >20 years.
  • Chronic cigarette/ beedi smoker (2-3 packets/day since last 3 years or more) with mild to moderate hyperlipidemia (LDL ranging 160-189 mg/dL, TC >200 mg/dL and/or HDL-C <40 mg/dL).
  • Being mentally competent and able to understand all study requirements and sign the informed consent form.

排除标准

  • Patients with Chronic obstructive pulmonary disease (COPD).
  • Patients with severe liver, renal, cardiac or brain diseases.
  • Unable to complete follow up.
  • Subjects on any medication like diuretics.
  • Allergic to any medication.
  • With a history of alcohol and/or drug abuse.

研究者

发起方
Olive Lifesciences Pvt Ltd

相似试验